List of insiders holdings for Aptinyx Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner |
2021-03-26 16:16:51 | 8,066,113 0 |
8,066,113 | Form 13D |
2 | ADAMS STREET PARTNERS LLC 10% Owner |
2023-06-27 14:13:31 | 5,395,996 0 |
5,395,996 | Form 13D |
3 | New Leaf Venture Management III L.L.C. New Leaf Venture Associates III L.P. New Leaf Ventures III L.P. New Leaf Biopharma Opportunities I L.P. New Leaf BPO Associates I L.P. 10% Owner |
2022-02-11 16:42:00 | 3,290,079 0 |
3,290,079 | Form 13D |
4 | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Heron Patrick J 10% Owner |
2021-05-04 12:31:59 | 3,195,055 0 |
3,195,055 | Form 13D |
5 | Topper James N Director |
2020-04-02 16:32:42 | 0 3,195,055 |
3,195,055 | Form 4 |
6 | KIDD ANDREW PRESIDENT AND CEO |
2023-01-05 16:16:09 | 700,000 0 |
700,000 | Form 4 |
7 | RIEDEL NORBERT G EXECUTIVE CHAIRMAN OF THE BOD |
2023-01-05 16:17:01 | 420,000 0 |
420,000 | Form 4 |
8 | KHANNA ASHISH CFO AND CBO |
2023-01-05 16:17:54 | 375,000 0 |
375,000 | Form 4 |
9 | Madsen Torsten M. Chief Medical Officer |
2019-01-30 18:58:38 | 232,600 0 |
232,600 | Form 4 |
10 | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner |
2023-03-16 16:19:28 | 192,805 0 |
192,805 | Form 13D |
11 | Houck David Chief Development Officer |
2019-01-07 16:26:07 | 50,000 0 |
50,000 | Form 4 |
12 | HOMBACH ROBERT J. Director |
2022-05-31 16:30:49 | 40,000 0 |
40,000 | Form 4 |
13 | ENRIGHT PATRICK G Director |
2022-05-31 16:30:48 | 40,000 0 |
40,000 | Form 4 |
14 | Miller Joan W. Director |
2022-05-31 16:31:41 | 40,000 0 |
40,000 | Form 4 |
15 | Gosebruch Henry O Director |
2022-05-31 16:31:02 | 40,000 0 |
40,000 | Form 4 |
16 | Sherman Rachel E. Director |
2022-05-31 16:30:48 | 40,000 0 |
40,000 | Form 4 |
17 | Gould Terry P Director |
2022-05-31 16:31:36 | 40,000 0 |
40,000 | Form 4 |
18 | O'Neill Gilmore Neil Director |
2022-05-31 16:32:02 | 40,000 0 |
40,000 | Form 4 |
19 | Koppel Adam Director 10% Owner |
2022-05-31 17:06:34 | 40,000 0 |
40,000 | Form 4 |
20 | MOSKAL JOSEPH R. Chief Scientific Officer |
2019-05-17 19:01:18 | 19,000 0 |
19,000 | Form 4 |
21 | GANTZ WILBUR H Director |
2020-04-02 16:29:32 | 13,366 0 |
13,366 | Form 4 |
22 | Ratcliffe Liam Director |
2019-04-02 16:24:06 | 4,123 0 |
4,123 | Form 4 |